Genetic and epidemiological risk factors for a malignant melanoma- predisposing phenotype: The great number of nevi

Genetic Epidemiology

Volumn 13, Issue 4, 1996, Pages 385-402

  Briollais, Laurent ^a   Chompret, Agnès ^b   Guilloud Bataille, Michel ^b   Feingold, Nicole ^b   Avril, Marie Françoise ^c   Demenais, Florence ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

melanoma; nevus; regressive model; risk factors; segregation analysis

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PHENOTYPE; SEGREGATION ANALYSIS;

EPIDEMIOLOGY, MOLECULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; NEVUS; PHENOTYPE; RISK FACTORS;

EID: 0029760241     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(1996)13:4<385::AID-GEPI7>3.0.CO;2-3     Document Type: Article

References (58)

1. Abel L, Golmard JL, Mallet A (1993): An autologistic model for the genetic analysis of familial binary data. Am J Hum Genet 53:894-907.
2. Aitken JF, Duffy DL, Green A, Youl P, MacLennanR, Martin NG (1994): Heterogeneity of melanoma risk in families of melanoma. Am J Epidemiol 11:961-973.
3. Bain C, Colditz GA, Willett WC, Stampfer MJ, Green A, Bronstein BR, Mihm MC, Rosner B, Hennekens H, Speizer FE (1988): Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease. Am J Epidemiol 127:703-712.
4. Bale S, Chakravarti A, Greene M (1986): Cutaneous malignant melanoma and familial dysplastic nevi: Evidence for an autosomal dominance and pleiotropy. Am J Hum Genet 38:188-196.
5. Bale S, Dracopoli N, Tucker M, Clark W, Fraser M, Stanger B, Green P, Donis-Keller H, Housman D, Greene M(1989): Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 1367-1372.
6. Barnes LM, Nordlung J (1987): Natural history of dysplastic nevi. Arch Dermatol 123:1059-1061.
7. Benhamou E, Laplanche A, Wartelle M, Faivre J, Gignoux M, Menegoz F, Schaffer P, Schraub S, Flamant R (1990): Incidence des Cancers en France 1978-1982. In INSERM (eds): "Statistiques de Santé." Paris, INSERM.
8. Bonney G (1984): On the statistical determination of major gene mechanisms in cutaneous human traits: Regressive models. Am J Med Genet 18:731-749.
9. Bonney G (1986): Regressive logistic models for familial diseases and other binary traits. Biometrics 42:611-625.
10. Bonney GE, Lathrop GM, Lalouel JM (1988): Combined linkage and segregation analysis using regressive models. Am J Hum Genet 43:29-37.
11. Cannon-Albright LA, Bishop DT, Goldgar DE, Skolnick MH (1991): Genetic epidemiology of cancer. In Lynch HT, Tautu P (eds): "Genetic Epidemiology of Cancer and Predisposing Lesions." Berlin: Springer-Verlag, pp 57-65.
12. Cannon-Albright LA, Meyer LJ, Goldgar DE, Lewis CM, McWorther WP, Jost M, Harrisson D, Anderson DE, Zone JJ, Skolnick M (1994): Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 54:6041-6044.
13. Clark W, Reimer R, Greene M, Ainsworth A, Mastrangelo M (1978): Origin of familial malignant melanoma from heritable melanocytic lesions: The B-K mole syndrome. Arch Dermatol 114:732-738.
14. Clark W, Elder D, Guery D IV, Epstein M, Greene M, Van Horm M (1984): A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma. Hum Phathol 15:1147-1165.
15. Dawson D, Elston R (1984): A bivariate problem in human genetics: Ascertainment of families through a correlated trait. Am J Med Genet 18:435-448.
16. Demenais F (1991a): Hereditary malignant melanoma. In Lynch HT, Fusaro R (eds): "HLA and Malignant Melanoma." Boca Raton, FL: CRC Press, Inc., pp 75-86.
17. Demenais F (1991b): Regression logistic models for familial diseases: A formulation assuming an underlying liability model. Am J Hum Genet 49:773-785.
18. Demenais F, Abel L (1989): Robustness of the unified model to shared environmental effects in the analysis of dichotomous traits. Genet Epidemiol 6:229-234.
19. Demenais F, Lathrop M (1994): REGRESS A computer program including the regressive approach into the LINKAGE package (abstract). Genet Epidemiol 11:291.
20. Demenais F, Chompret A, Guilloud-Bataille M, Feingold N, Grange F, Avril MF (1994): Segregation analysis of cutaneous malignant melanoma in France: Role of genetic and epidemiological risk factors. Presented at the 26th Annual Meeting of the European Society of Human Genetics, Paris (France) June 1-5, 1994.
21. Easton D, Cox G, MacDonald M, Ponder B (1991): Genetic susceptibility to nevi: A twin study. Br J Cancer 64:1164-1167.
22. Elston R, Sobel E (1979): Sampling consideration in the gathering and analysis of pedigree data. Am J Hum Genet 31:62-69.
23. Elston R, Steward J (1971): A general model for the genetic analysis of pedigree data. Hum Hered 21:523-542.
24. Elwood JM, Gallagher RP, Hill GB, Pearson JCG (1985): Cutaneous melanoma in relation to intermittent and constant sun exposure: The Western Canada melanoma study. Int J Cancer 35:427-433.
25. Epstein JH, Epstein WL, Nakori T (1967): Production of melanomas from DMBA induced blue nevi in hairless mice with ultraviolet light. J Natl Cancer Inst 38:19-30.
26. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Krüger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Holzmann I, Orfanos C (1994): Associated factors in the prevalence of more than 5 common melanocytic nevi, atypical melanocytic nevi and actinic lentigines. J Invest Dermatol 102:700-705.
27. Goldgar D, Cannon-Albright L, Meyer L, Piepkorn M, Zone JJ, Skolnick M (1991): Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst 83(23): 1726-1733.
28. Goldstein A, Dracopoli N, Ho E, Fraser M, Kearns K, Bale S, McBride O, Clark W (1993a): Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome Ip, and evidence for genetic heterogeneity. Am J Hum Genet 52:537-550.
29. Goldstein AM, Tucker MA, Crutcher WA, Harge P, Sagebiel RW (1993b): The inheritance pattern of dysplastic naevi in families of dysplastic naevus patients. Melanoma Res 3:15-22.
30. Goldstein A, Dracopoli N, Engelstein M, Fraser M, Clark W, Tucker M (1994): Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p and evidence for genetic heterogeneity. Am J Hum Genet 54:489-496.
31. Grange F, Chompret A, Guilloud-Bataille, Guillaume JC, Margulis A, Prade M, Demenais F (1995): Comparison between familial and non familial melanoma in France. Arch Dermatol 131:1154-1159
32. Green A, Bain C, MacLennan R, Siskind V (1986): Epidemiology of malignant melanoma. In Gallagher RP (ed): "Risk Factors for Cutaneous Melanoma in Queensland. Recent Results in Cancer Research." Berlin: Springer-Verlag, pp 76-97.
33. Greene M, Fraumeni J (1979): The hereditary variant of malignant melanoma. In Clark WH, Goldman LI, Mastrangelo MJ (eds): "Human Malignant Melanoma," New York: Grune and Stratton, pp 139-166.
34. Greene M, Goldin L, Clark W, Lovrien E, Kraemer K, Tucker M, Elder D, Fraser M, Rowe S (1983): Familial cutaneous malignant melanoma: Autosomal dominant trait possibly linked to the Rh locus. Proc Natl Acad Sci USA 80:6071-6075.
35. Grob JJ, Andrac L, Romano MH, Davin D, Collet-Vilette AM , Mung MH, Bonerandi JJ (1988): Dysplastic nevus in non familial melanoma: A clinical-pathological study of 101 cases. Br J Dermatol 118:745-752.
36. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano M, Collet A, Noe M, Disconstanzo M, Bonerandi J (1990): Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 66:387-393.
37. Holman C, Armstrong BK (1984): Pigmentary traits, ethnic origin, benign nevi and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 72:257-266.
38. Hussain Z, Pathak MA, Flotte T, Wick MM (1991): Role of ultraviolet radiation in the induction of melanocytic tumors in hairless mice following 7,12-dimethyl-benz(a)anthracene application and ultraviolet irradiation. Cancer Res 51:4964-4970.
39. Hussussian C, Sreuewing J, Goldstein A, Higgins P, Ally D, Sheahan M, Clark W, Tucker M, Dracopoli N (1994): Germline p16 mutations in familial melanoma. Nat Genet 8:15-21.
40. IARC (1987): "Cancer Incidence in Five Continents." IARC Scientific Publications No. 88, Vol V, Lyon: IARC.
41. Kamb A, Shsttuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Andersen DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA (1994): Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8:22-26.
42. Kelly JW, Crutcher WA, Sagebiel RW (1986): Clinical diagnosis of dysplastic melanocytic nevi. J Am Acad Dermatol 14:1044-1052.
43. Lathrop M, Lalouel JM, Ott J (1984): Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443-3446.
44. Lawson DD, Moore DH, Schneider JS, Sagebiel R (1994): Nevus counting as a risk factor for melanoma: Comparison of self-count with count by physician. J Am Acad Dermatol 31:438-444.
45. Lynch H, Frichot B, Lynch J (1978): Familial atypical multiple mole melanoma syndrome. J Med Genet 15:352.
46. MacKie RM, Aitchinson T (1982): Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 46:955-960.
47. MacKie RM, English J, Aitchison TC, Fitzsimons CP, Wilson P (1985): The number and distribution of benign pigmented moles (Melanocytic naevi) in a healthy British population. Br J Dermatol 113:167-174.
48. MacLennan R, Green AC, McLeod GRC, Martin NG (1992): Increasing incidence of cutaneous melanoma in Queensland, Australia. J Natl Cancer Inst 84:1427-1432.
49. Piepkorn M, Meyer L, Goldgar D, Seuchter S, Cannon-Albright L, Skolnick M, Zone JJ (1989): The dysplastic melanocytic nevus: A prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol 20:407-415.
50. ink4 function. Nat Genet 10:114-116.
51. Reimer RR, Clark WH, Greene MH, Ainsworth AM, Fraumeni JF (1978): Precursor lesions in familial melanoma: A new genetic preneoplastic syndrome. JAMA 239:744-746.
52. Risch N, Sherman S (1992): Genetic analysis workshop 7: Summary of the melanoma workshop. Cytogenet Cell Genet 59:148.
53. Sellers TA, Bailey-Wilson JE, Elston RC, Wilson AF, Elston GZ, Ooi WL, Rotschild H (1990): Evidence for Mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 82:1272-1279.
54. Swerdlow A, English J, MacKie R, O'Doherty C, Hunter J, Clark J, Hole D (1986): Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 292:1555-1559.
55. Thein SL, Sampietro M, Rohde K, Rochette J, Weatherall DJ, Lathrop MG, Demenais F (1994): Detection of a major gene for heterocellular hereditary persistence of foetal hemoglobin after accounting for genetic modifiers. Am J Hum Genet 54:214-228.
56. Tucker M, Fraser M, Goldstein A, Elder D, Guery D IV, Organic S (1993): Risk of melanoma in melanomaprone families. J Invest Dermatol 100:350S-355S.
57. Weinstein B, Gattoni-Celli S, Kirschmeier P, Lambert M, Hsiao W, Backer J, Jeffrey A (1983): Cellular and molecular biology of neoplasia. In Mak TW, Tannaki (eds): "Multistage Carcinogenesis Involves Multiple Genes and Multiple Mechanisms." New York: Alan R. Liss, Inc. pp 127-138.
58. White E, Kirkpatrick CS, Lee JAH (1994): Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure. Am J Epidemiol 139:857-868.